References
- Dang B, Chen W, He W, Chen G. Rehabilitation treatment and progress of traumatic brain injury dysfunction. Neural Plast. 2017;2017:1582182. doi:https://doi.org/10.1155/2017/1582182. Epub 2017 Apr 11. PMID: 28491478; PMCID: PMC5405588.
- Galgano M, Toshkezi G, Qiu X, Russell T, Chin L, Zhao LR. Traumatic brain injury: current treatment strategies and future endeavors. Cell Transplant. 2017 Jul;26(7):1118–30. doi:https://doi.org/10.1177/0963689717714102. PMID: 28933211; PMCID: PMC5657730.
- Grenier K, Ponnambalam F, Lee D, Lauwers R, Bhalerao S. Cannabis in the treatment of traumatic brain injury: a primer for clinicians. Can J Neurol Sci. Sept 25 2019:1–7. doi:https://doi.org/10.1017/cjn.2019.298. Epub ahead of print. PMID: 31551104.
- DISA Global Solutions. Map of marijuana legality by state. Houston (TX): DISA; 2020 Nov 4 [accessed 2020 Dec 22]. https://disa.com/map-of-marijuana-legality-by-state.
- Parmar JR, Forrest BD, Freeman RA. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs. Res Social Adm Pharm. 2016 Jul-Aug;12(4):638–54. doi:https://doi.org/10.1016/j.sapharm.2015.09.002. Epub 2015 Sep 16. PMID: 26443472.
- Kramer JL. Medical marijuana for cancer. CA Cancer J Clin. 2015 Mar;65(2):109–22. doi:https://doi.org/10.3322/caac.21260. Epub 2014 Dec 10. PMID: 25503438.
- Coussens NP, Sittampalam GS, Jonson SG, Hall MD, Gorby HE, Tamiz AP, McManus OB, Felder CC, Rasmussen K. The opioid crisis and the future of addiction and pain therapeutics. J Pharmacol Exp Ther. 2019 Nov;371(2):396–408. doi:https://doi.org/10.1124/jpet.119.259408. Epub 2019 Sep 3. PMID: 31481516; PMCID: PMC6863454.
- Centers for Disease Control and Prevention. Drug overdose deaths. Washington (DC): U.S. Department of Health & Human Services; 2020 Mar 19 [accessed 2020 Oct 10]. https://www.cdc.gov/drugoverdose/data/statedeaths.htm.
- Slawek D, Meenrajan SR, Alois MR, Comstock Barker P, Estores IM, Cook R. Medical cannabis for the primary care physician. J Prim Care Community Health. 2019 Jan-Dec;10:215013271988483. PMID: 31646929; PMCID: PMC6820188. doi:https://doi.org/10.1177/2150132719884838
- Goldsmith RS, Targino MC, Fanciullo GJ, Martin DW, Hartenbaum NP, White JM, Franklin P. Medical marijuana in the workplace: challenges and management options for occupational physicians. J Occup Environ Med. 2015 May;57(5):518–25. doi:https://doi.org/10.1097/JOM.0000000000000454. PMID: 25951421; PMCID: PMC4410963.
- Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018 Nov;84(11):2477–82. doi:https://doi.org/10.1111/bcp.13710. Epub 2018 Aug 7. PMID: 30001569; PMCID: PMC6177698.
- Shohami E, Cohen-Yeshurun A, Magid L, Algali M, Mechoulam R. Endocannabinoids and traumatic brain injury. Br J Pharmacol. 2011 Aug;163(7):1402–10. doi:https://doi.org/10.1111/j.1476-5381.2011.01343.x. PMID: 21418185; PMCID: PMC3165950.
- Burggren AC, Shirazi A, Ginder N, London ED. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abuse. 2019;45(6):563–79. doi:https://doi.org/10.1080/00952990.2019.1634086. Epub 2019 Jul 31. PMID: 31365275; PMCID: PMC7027431.
- Hryhorowicz S, Walczak M, Zakerska-Banaszak O, Słomski R, Skrzypczak-Zielińska M. Pharmacogenetics of Cannabinoids. Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):1–12. doi:https://doi.org/10.1007/s13318-017-0416-z. PMID: 28534260; PMCID: PMC5794848.
- Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem. 2005 Oct;95(2):437–45. doi:https://doi.org/10.1111/j.1471-4159.2005.03380.x. Epub 2005 Aug 8. PMID: 16086683.
- Corrigan F, Mander KA, Leonard AV, Vink R. Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation. J Neuroinflammation. 2016;13:264.
- Neavyn MJ, Blohm E, Babu KM, Bird SB. Medical marijuana and driving: a review. J Med Toxicol. 2014 Sept;10(3):269–79. doi:https://doi.org/10.1007/s13181-014-0393-4. PMID: 24648180; PMCID: PMC4141931.
- Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007 Aug 4;(8):1770–804. doi:https://doi.org/10.1002/cbdv.200790152. PMID: 17712819; PMCID: PMC2689518.
- Braun M, Khan ZT, Khan MB, Kumar M, Ward A, Achyut BR, Arbab AS, Hess DC, Hoda MN, Baban B, et al. Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization. Brain Behav Immun. 2018 Feb;68:224–37. doi:https://doi.org/10.1016/j.bbi.2017.10.021. Epub 2017 Oct 24. PMID: 29079445; PMCID: PMC5767553.
- Schurman LD, Lichtman AH. Endocannabinoids: a promising impact for traumatic brain injury. Front Pharmacol. 2017 Feb 17;8:69. doi:https://doi.org/10.3389/fphar.2017.00069. PMID: 28261100; PMCID: PMC5314139.
- Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol. 2000 Jan;129(2):227–30. doi:https://doi.org/10.1038/sj.bjp.0703050. PMID: 10694225; PMCID: PMC1571834.
- Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, Freund TF. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 2004 Jul;20(2):441–58. doi:https://doi.org/10.1111/j.1460-9568.2004.03428.x. PMID: 15233753.
- Herkenham M, Lynn AB, Johnson MR, Melvin LS, De Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 1991 Feb;11(2):563–83. doi:https://doi.org/10.1523/JNEUROSCI.11-02-00563.1991. PMID: 1992016; PMCID: PMC6575215.
- Nomura DK, Hudak CS, Ward AM, Burston JJ, Issa RS, Fisher KJ, Abood ME, Wiley JL, Lichtman AH, Casida JE. Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5875–78. doi:https://doi.org/10.1016/j.bmcl.2008.08.007. Epub 2008 Aug 6. PMID: 18752948; PMCID: PMC2593629.
- Vakil E. The effect of moderate to severe traumatic brain injury (TBI) on different aspects of memory: a selective review. J Clin Exp Neuropsychol. 2005 Nov;27(8):977–1021. doi:https://doi.org/10.1080/13803390490919245. PMID: 16207622.
- Corcoran L, Roche M, Finn DP. The role of the brain’s endocannabinoid system in pain and its modulation by stress. Int Rev Neurobiol. 2015;125:203–55. doi:https://doi.org/10.1016/bs.irn.2015.10.003. Epub 2015 Nov 6. PMID: 26638768.
- Raghupathi R. Cell death mechanisms following traumatic brain injury. Brain Pathol. 2004 Apr;14(2):215–22. doi:https://doi.org/10.1111/j.1750-3639.2004.tb00056.x. PMID: 15193035.
- Tchantchou F, Tucker LB, Fu AH, Bluett RJ, McCabe JT, Patel S, Zhang Y. The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury. Neuropharmacology. 2014 Oct;85:427–39. doi:https://doi.org/10.1016/j.neuropharm.2014.06.006. Epub 2014 Jun 14. PMID: 24937045; PMCID: PMC4437642.
- Zhang J, Teng Z, Song Y, Hu M, Chen C. Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury. J Cereb Blood Flow Metab. 2015 Mar;35(3):443–53. doi:https://doi.org/10.1038/jcbfm.2014.216. Epub 2014 Dec 10. Erratum in: J Cereb Blood Flow Metab. 2015 Apr;35(4):706.PMID: 25492114; PMCID: PMC4348384.
- Amenta PS, Jallo JI, Tuma RF, Elliott MB. A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. J Neurosci Res. 2012 Dec;90(12):2293–305. doi:https://doi.org/10.1002/jnr.23114. Epub 2012 Aug 18. PMID: 22903455.
- Hillard CJ. Endocannabinoids and vascular function. J Pharmacol Exp Ther. 2000 Jul;294(1):27–32. PMID: 10871291.
- Benyó Z, Ruisanchez É, Leszl-Ishiguro M, Sándor P, Pacher P. Endocannabinoids in cerebrovascular regulation. Am J Physiol Heart Circ Physiol. 2016 Apr 1;310(7):H785–801. doi:https://doi.org/10.1152/ajpheart.00571.2015. Epub 2016 Jan 29. PMID: 26825517; PMCID: PMC4865067.
- Russo EB. Cannabis therapeutics and the future of neurology. Front Integr Neurosci. 2018 Oct 18;12:51. doi:https://doi.org/10.3389/fnint.2018.00051. PMID: 30405366; PMCID: PMC6200872.
- Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, Alexandrovich A, Shohami E. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis. 2006 May;22(2):257–64. doi:https://doi.org/10.1016/j.nbd.2005.11.004. Epub 2005 Dec 20. PMID: 16364651.
- Katz PS, Sulzer JK, Impastato RA, Teng SX, Rogers EK, Molina PE. Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury. J Neurotrauma. 2015 Mar 1;32(5):297–306. doi:https://doi.org/10.1089/neu.2014.3508. Epub 2014 Dec 19. PMID: 25166905; PMCID: PMC4348366.
- Tchantchou F, Zhang Y. Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury. J Neurotrauma. 2013 Apr 1;30(7):565–79. doi:https://doi.org/10.1089/neu.2012.2647. Epub 2013 Apr 5. PMID: 23151067; PMCID: PMC3636589.
- Bullock R, Zauner A, Woodward JJ, Myseros J, Choi SC, Ward JD, Marmarou A, Young HF. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg. 1998 Oct;89(4):507–18. doi:https://doi.org/10.3171/jns.1998.89.4.0507. PMID: 9761042.
- Farrell D, Bendo AA. Perioperative management of severe traumatic brain injury: what is new? Curr Anesthesiol Rep. 2018;8(3):279–89. doi:https://doi.org/10.1007/s40140-018-0286-1. Epub 2018 Aug 14. PMID: 30147453; PMCID: PMC6096919.
- Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA. 2015 Jun 23-30;313(24):2474–83. doi:https://doi.org/10.1001/jama.2015.6199. Erratum in: JAMA. 2016 Sep 6;316(9):995.PMID: 26103031.
- Mestre L, Correa F, Arévalo-Martín A, Molina-Holgado E, Valenti M, Ortar G, Di Marzo V, Guaza C. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. J Neurochem. 2005 Mar;92(6):1327–39. doi:https://doi.org/10.1111/j.1471-4159.2004.02979.x. PMID: 15748152.
- Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 2001 Oct 4;413(6855):527–31. doi:https://doi.org/10.1038/35097089. PMID: 11586361.
- Johnson VE, Stewart W, Smith DH. Traumatic brain injury and amyloid-β pathology: a link to Alzheimer’s disease? Nat Rev Neurosci. 2010 May;11(5):361–70. doi:https://doi.org/10.1038/nrn2808. PMID: 20216546; PMCID: PMC3979339.
- Goldstein LE, Fisher AM, Tagge CA, Zhang XL, Velisek L, Sullivan JA, Upreti C, Kracht JM, Ericsson M, Wojnarowicz MW, et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012 May 16;4(134):134ra60. doi:https://doi.org/10.1126/scitranslmed.3003716. PMID: 22593173; PMCID: PMC3739428.
- Smith DH, Chen XH, Nonaka M, Trojanowski JQ, Lee VM, Saatman KE, Leoni MJ, Xu BN, Wolf JA, Meaney DF. Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J Neuropathol Exp Neurol. 1999 Sept;58(9):982–92. doi:https://doi.org/10.1097/00005072-199909000-00008. PMID: 10499440.
- Zec RF, Zellers D, Belman J, Miller J, Matthews J, Femeau-Belman D, Robbs R. Long-term consequences of severe closed head injury on episodic memory. J Clin Exp Neuropsychol. 2001 Oct;23(5):671–91. doi:https://doi.org/10.1076/jcen.23.5.671.1247. Erratum in: J Clin Exp Neuropsychol 2002 Feb;24(1):130.PMID: 11778644.
- Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol. 2013;64:21–47. doi:https://doi.org/10.1146/annurev-psych-113011-143739. Epub 2012 Jul 12. PMID: 22804774.
- Martinez-Vargas M, Morales-Gomez J, Gonzalez-Rivera R, Hernandez-Enriquez C, Perez-Arredondo A, Estrada-Rojo F, Navarro L. Does the neuroprotective role of anandamide display diurnal variations? Int J Mol Sci. 2013 Nov 27;14(12):23341–55. doi:https://doi.org/10.3390/ijms141223341. PMID: 24287910; PMCID: PMC3876049.
- Abrams DI, Guzman M. Cannabis in cancer care. Clin Pharmacol Ther. 2015 Jun;97(6):575–86. doi:https://doi.org/10.1002/cpt.108. Epub 2015 Apr 17. PMID: 25777363.
- Guha A. Management of traumatic brain injury: some current evidence and applications. Postgrad Med J. 2004 Nov;80(949):650–53. doi:https://doi.org/10.1136/pgmj.2004.019570. PMID: 15537849; PMCID: PMC1743133.
- Royo NC, Shimizu S, Schouten JW, Stover JF, McIntosh TK. Pharmacology of traumatic brain injury. Curr Opin Pharmacol. 2003 Feb 3;(1):27–32. doi:https://doi.org/10.1016/s1471-4892(02)00006-1. PMID: 12550738.
- Maas AI, Murray G, Henney H 3rd, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N, Pharmos TBI investigators. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 2006 Jan 5;(1):38–45. doi:https://doi.org/10.1016/S1474-4422(05)70253-2. PMID: 16361021.
- Nguyen BM, Kim D, Bricker S, Bongard F, Neville A, Putnam B, Smith J, Plurad D. Effect of marijuana use on outcomes in traumatic brain injury. Am Surg. 2014 Oct;80(10):979–83. doi:https://doi.org/10.1177/000313481408001015. PMID: 25264643.
- Leskovan JJ, Patel PD, Pederson JM, Moore A, Afaneh A, Brown LR. The effects of alcohol and marijuana on survival after severe traumatic brain injury: a retrospective cohort study. Ann Med Surg (Lond). 2020 Jul 22;57:201–04. doi:https://doi.org/10.1016/j.amsu.2020.07.031. PMID: 32793339; PMCID: PMC7406975.
- Taghavi S, Ramirez S, Duchesne J, Tatum D. Preinjury use of marijuana and outcomes in trauma patients. J Surg Res. 2021 Jan;257:42–49. doi:https://doi.org/10.1016/j.jss.2020.07.011. Epub 2020 Aug 17. PMID: 32818783.
- Schier JG, Meiman JG, Layden J, Mikosz CA, VanFrank B, King BA, Salvatore PP, Weissman DN, Thomas J, Melstrom PC, et al. Severe pulmonary disease associated with electronic-cigarette-product use - interim guidance. MMWR Morb Mortal Wkly Rep. 2019 Sept 13;68(36):787–90. doi:https://doi.org/10.15585/mmwr.mm6836e2. Erratum in: MMWR Morb Mortal Wkly Rep. 2019 Sep 27;68(38):830.PMID: 31513561; PMCID: PMC6755818.
- Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde MW, Navon L, Hoots B, Salvatore PP, Elderbrook M, et al. Pulmonary illness related to E-cigarette use in illinois and wisconsin - final report. N Engl J Med. 2020 Mar 5;382(10):903–16. doi:https://doi.org/10.1056/NEJMoa1911614. Epub 2019 Sep 6. PMID: 31491072.
- Seamon MJ, Fass JA, Maniscalco-Feichtl M, Abu-Shraie NA. Medical marijuana and the developing role of the pharmacist. Am J Health Syst Pharm. 2007 May 15;64(10):1037–44. doi:https://doi.org/10.2146/ajhp060471. PMID: 17494903.
- Bondallaz P, Favrat B, Chtioui H, Fornari E, Maeder P, Giroud C. Cannabis and its effects on driving skills. Forensic Sci Int. 2016 Nov;268:92–102. doi:https://doi.org/10.1016/j.forsciint.2016.09.007. Epub 2016 Sep 16. PMID: 27701009.
- Heishman SJ, Huestis MA, Henningfield JE, Cone EJ. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol Biochem Behav. 1990 Nov;37(3):561–65. doi:https://doi.org/10.1016/0091-3057(90)90028-g. PMID: 1965045.
- Ashtari M, Avants B, Cyckowski L, Cervellione KL, Roofeh D, Cook P, Gee J, Sevy S, Kumra S. Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res. 2011 Aug;45(8):1055–66. doi:https://doi.org/10.1016/j.jpsychires.2011.01.004. Epub 2011 Feb 5. PMID: 21296361; PMCID: PMC3303223.
- Ware MA, Wang T, Shapiro S, Collet JP, COMPASS study team. Cannabis for the management of pain: assessment of safety study (COMPASS). J Pain. 2015 Dec 16;(12):1233–42. doi:https://doi.org/10.1016/j.jpain.2015.07.014. Epub 2015 Sep 16. PMID: 26385201.
- Crane NA, Schuster RM, Gonzalez R. Preliminary evidence for a sex-specific relationship between amount of cannabis use and neurocognitive performance in young adult cannabis users. J Int Neuropsychol Soc. 2013 Oct;19(9):1009–15. doi:https://doi.org/10.1017/S135561771300088X. Epub 2013 Aug 20. PMID: 23962414; PMCID: PMC3895398.
- Lafaye G, Karila L, Blecha L, Benyamina A. Cannabis, cannabinoids, and health. Dialogues Clin Neurosci. 2017 Sept;19(3):309–16. doi:https://doi.org/10.31887/DCNS.2017.19.3/glafaye. PMID: 29302228; PMCID: PMC5741114.
- Calvigioni D, Hurd YL, Harkany T, Keimpema E. Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur Child Adolesc Psychiatry. 2014 Oct;23(10):931–41. doi:https://doi.org/10.1007/s00787-014-0550-y. Epub 2014 May 3. PMID: 24793873; PMCID: PMC4459494.
- Dong C, Chen J, Harrington A, Vinod KY, Hegde ML, Hegde VL. Cannabinoid exposure during pregnancy and its impact on immune function. Cell Mol Life Sci. 2019 Feb;76(4):729–43. doi:https://doi.org/10.1007/s00018-018-2955-0. Epub 2018 Oct 29. PMID: 30374520; PMCID: PMC6632091.
- Pearson-Dennett V, Todd G, Wilcox RA, Vogel AP, White JM, Thewlis D. History of cannabis use is associated with altered gait. Drug Alcohol Depend. 2017 Sept 1;178:215–22. doi:https://doi.org/10.1016/j.drugalcdep.2017.05.017. Epub 2017 Jun 21. PMID: 28666180.
- Salomonsen-Sautel S, Sakai JT, Thurstone C, Corley R, Hopfer C. Medical marijuana use among adolescents in substance abuse treatment. J Am Acad Child Adolesc Psychiatry. 2012 Jul;51(7):694–702. doi:https://doi.org/10.1016/j.jaac.2012.04.004. Epub 2012 May 26. PMID: 22721592; PMCID: PMC3381870.
- Swartz R. Medical marijuana users in substance abuse treatment. Harm Reduct J. 2010 Mar 5;7:3. doi:https://doi.org/10.1186/1477-7517-7-3. PMID: 20202221; PMCID: PMC2848643.
- DiGiorgio AM, Wittenberg BA, Crutcher CL 2nd, Kennamer B, Greene CS, Velander AJ, Wilson JD, Tender GC, Culicchia F, Hunt JP. The impact of drug and alcohol intoxication on glasgow coma scale assessment in patients with traumatic brain injury. World Neurosurg. 2020 Mar;135:e664–e670. doi:https://doi.org/10.1016/j.wneu.2019.12.095. Epub 2019 Dec 24. PMID: 31881342.
- Hawley LA, Ketchum JM, Morey C, Collins K, Charlifue S. Cannabis use in individuals with spinal cord injury or moderate to severe traumatic brain injury in Colorado. Arch Phys Med Rehabil. 2018 Aug;99(8):1584–90. doi:https://doi.org/10.1016/j.apmr.2018.02.003. Epub 2018 Mar 7. PMID: 29524396.